Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study.

Royston, Léna; Royston, Eva; Masouridi-Levrat, Stavroula; Vernaz, Nathalie; Chalandon, Yves; Van Delden, Christian; Neofytos, Dionysios

Royston, Léna; Royston, Eva; Masouridi-Levrat, Stavroula; Vernaz, Nathalie; Chalandon, Yves; Van Delden, Christian; Neofytos, Dionysios.

Afiliación

Royston L; Division of Infectious Diseases, University Hospital of Geneva, 1205 Geneva, Switzerland.
Royston E; Bone Marrow Transplant Unit, Division of Hematology, University Hospital of Geneva, 1205 Geneva, Switzerland.
Masouridi-Levrat S; Bone Marrow Transplant Unit, Division of Hematology, University Hospital of Geneva, 1205 Geneva, Switzerland.
Vernaz N; Medical Directorate, University Hospital of Geneva, 1205 Geneva, Switzerland.
Chalandon Y; Bone Marrow Transplant Unit, Division of Hematology, University Hospital of Geneva, 1205 Geneva, Switzerland.
Van Delden C; Division of Infectious Diseases, University Hospital of Geneva, 1205 Geneva, Switzerland.
Neofytos D; Division of Infectious Diseases, University Hospital of Geneva, 1205 Geneva, Switzerland.

Vaccines (Basel) ; 9(4)2021 Apr 12.

Article en En | MEDLINE | ID: mdl-33921218

Palabras clave

allogeneic hematopoietic cell transplant recipients; cytomegalovirus (CMV); letermovir; prophylaxis; recurrent CMV infection

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google